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Background The burden of non–communicable diseases is growing, 
particularly in developing countries. The greatest economic burden 
is due to dementia, the prevalence of which is rising with increasing 
longevity. In Africa, where the rate of increase of elderly persons is 
the fastest in the world, dementia is normally dismissed as a part of 
normal ageing. The lack of awareness means that many patients are 
suffering undiagnosed. This review aims to assess the information on 
the prevalence of dementia in Africa in order to estimate the current 
burden.
Methods A parallel search of Medline, EMBASE and Global Health 
limited to post–1980 found only 10 relevant studies. Data on preva-
lence and risk factors were extracted and analysed. We modelled the 
available information and used the UN population figures for Africa 
to determine the age-specific and overall burden of dementia.
Results The overall prevalence of dementia in adults older than 50 
years in Africa was estimated to be about 2.4%, which translates to 
2.76 million people living with a disease in 2010. About 2.10 millions 
of them live in Sub–Saharan Africa. Prevalence was the highest among 
females aged 80 and over (19.7%) and there was little variation be-
tween regions. Alzheimer disease was the most prevalent cause of de-
mentia (57.1%) followed by vascular dementia (26.9%). The main 
risk factors were increasing age, female sex and cardiovascular disease.
Conclusions Information on dementia prevalence in Africa is very 
limited. Further research will not only provide a more reliable estimate 
of prevalence, and consequently the burden of disease, but will also 
raise awareness of the problem. This is critical in promoting help-seek-
ing behaviour and generating the political commitment to make de-
mentia a public health priority in Africa.
Non-communicable diseases (NCDs) have become the leading causes of 
death globally [1]. NCDs kill more people than all other diseases com-
bined, accounting for 63% of deaths in 2008 [2,3]. It is often under-ap-
preciated that nearly 80% of these deaths occur in low– and middle–in-
come countries (LMICs), where ageing is presently occurring at a faster 
rate [1]. From 1950 to 2009, 68% of the increase in persons aged 60 or 
over was seen in LMIC [4].
This is true even for African nations, where the average life expectancy is 
still only 55.2 years, due to high mortality from communicable, maternal, 
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perinatal and nutritional causes [5]. The current African 
context is described in more detail in Box 1 while Box 2 
briefly describes the characteristics of the disease of inter-
est [5,6].
NCDs are not only a health problem, but also a social prob-
lem, significantly contributing to poverty. Most NCDs are 
chronic and lead to continued expenditures that can trap 
households in cycles of debt and illness [20]. They tend to 
disproportionately affect poorer individuals, largely due to 
inequalities in the distribution of major risk factors [20]. 
The UN's High-Level Meeting in September 2011 put the 
global pandemic of NCDs at the top of the global political 
agenda [9,21]. Gross disparities in resources exist within 
and between developed and developing countries: new 
drug treatments are expensive; access to care is often de-
pendent upon sufferers' means to pay; and health care re-
sources are unevenly distributed between rural and urban 
Box 1 A summary of the current African context
In Sub–Saharan Africa nearly 6% of adults aged 15–49 are 
HIV positive, and malaria kills a million children under the 
age of five each year, with childhood pneumonia, diarrhoea 
and other infectious diseases still being a major cause of mor-
tality [6]. Nevertheless, non-communicable diseases (NCDs) 
are expected to exceed them all as the most common cause 
of death by 2030 [1].
Middle class population of Africa has tripled over the last 
thirty years to become more than 34% of the continent’s pop-
ulation [7]. This growth means more people will seek better 
health care for themselves and their families and this is like-
ly to contribute to patterns of morbidity and mortality. As its 
population is ageing faster than that in high-income coun-
tries, the necessity of prevalence data from Africa must be 
emphasised [8]. The health of the elderly is of special impor-
tance in this context, as they are filling the roles of the gen-
eration decimated by HIV/AIDS, particularly in sub-Saharan 
Africa [9]. Only a few community-based studies have been 
carried out in Africa and these have often reported a low 
prevalence of dementia [10]. Suggested reasons for this in-
clude: (i) poor access or reluctance to seek medical care; (ii) 
the belief that an elderly person has completed their useful 
life; (iii) differential survival rates; (iv) hiding of cases by rel-
atives concerned about the stigma of mental disease; (v) de-
fective case finding techniques; and (vi) the belief that de-
mentia is a normal part of ageing [11].
Without appropriate and sufficient knowledge on the bur-
den of dementia in Africa, this disease will not be considered 
a public health priority, making it difficult to secure resourc-
es necessary to improve the management of patients [12]. 
However, the recent report by the World Health Organiza-
tion stated that “...there is no more powerful tool for obtain-
ing political and financial commitment than locally derived 
and relevant data” [13]. A reliable estimate of the prevalence 
could therefore considerably advance further research into 
the burden, as well as increase understanding of dementia 
in Africa and low– and middle–income countries (LMICs) 
in general.
districts [13-17]. Health services in LMICs are ill-equipped 
to meet the needs of older persons, as health care is primar-
ily clinic-based, with treatments oriented towards acute 
rather than chronic conditions [2].
One of the NCDs expected to pose the greatest problem to 
health systems in LMICs in the coming decades is demen-
tia. It has a uniquely profound effect on disability and need 
for care, being the major cause of dependency among the 
elderly worldwide [13,18]. Dementia affects not only indi-
viduals but also their families on personal, emotional, so-
cial and financial levels, driving millions of households be-
low the poverty line and making dementia a global health 
priority [14-17,19]. It has been estimated 35.6 million peo-
ple suffer from it worldwide – 0.5% of the world’s total 
population – and this is set to increase to over 115 million 
by 2050 [13,19]. Slightly more than half of the current suf-
ferers live in LMICs, with a predicted increase of this figure 
to 71% by 2050 if the present trends continue [22]. The 
global economic impact of dementia for 2010 was estimat-
ed to amount to approximately US$ 600 billion, corre-
sponding to 1.0% of the aggregated worldwide GDP, but 
per capita costs varied from US$ 868 in low-income coun-
tries, US$ 3109 in middle-income countries, to US$ 32685 
in high-income countries [1].
As a part of international response to dementia, the WHO 
launched the Mental Health Gap Action Programme in 
2008, with dementia as a priority condition, and it recent-
ly published a large report “Dementia: A public health pri-
ority” [1,13,15]. The group Alzheimer Disease Internation-
al keeps publishing the “World Alzheimer's Report” 
annually, as a laudable attempt to keep track on the burden 
and impact of the condition [14,16,17]. Finally, in 2011, 
the High-Level Meeting of the United Nations General As-
sembly on prevention and control of NCDs acknowledged 
that “mental and neurological disorders, including Al-
zheimer’s disease, are an important cause of morbidity and 
contribute to the global non–communicable disease bur-
den” [13]. Despite these, addressing the problem of demen-
tia remains a low priority in most LMICs, which tend to 
prioritise control and eradication of communicable diseas-
es and reproductive, maternal, and child health. This is not 
surprising because even in high-income countries the pri-
oritised NCDs are mainly those that cause early death, such 
as cancer and heart disease, and not those that cause years–
lived–with–disability (YLD), such as dementia [7,23].
The objective of this paper is to systematically review publi-
cally available epidemiological studies on dementia and its 
main forms (Alzheimer disease and vascular dementia) in 
Africa and to estimate the burden of dementia in Africa in 
2010. It also investigates differences in prevalence by age and 
gender, to highlight the segments of the population requir-
ing the most urgent attention. The paper also aims to suggest 
policy implications and to contribute to an improvement in 
evidence and information on dementia in LMICs.
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METHODS
Definitions and study design 
considerations
The chronic nature of dementia makes an estimate of prev-
alence more suitable than one of incidence [17]. Prevalence 
here refers to people aged 50 years and over with dementia 
in 2010. This age cut–off value (50+) was introduced be-
cause 50 years was the lowest age of participants included 
in the studies in this review.
Search strategy
After initial scoping exercises to identify key words and 
Medical Subject Headings (MeSH) and input from a librar-
ian to choose the final search terms (Table 1), a system-
atic review of published literature was undertaken across 
the following databases via OVID:
1) Medline (1980–Current) on 22 January 2012;
2) EMBASE (1980–Current) on 9 February 2012;
3) Global Health (1980–Current) on 9 February 2012.
An additional search of Google Scholar and the hand-
searching of the selected studies’ reference lists produced 
no additional results. Specific countries were those identi-
fied by the World Bank list of economies (January 2012) 
as being LMICs in Africa. Limitations were placed to stud-
ies concerning humans and those published after 1980.
Study selection
The inclusion criteria used to screen the useful papers were: 
(i) community-based studies; (ii) conducted in LMICs in 
Dementia is a syndrome, usually of a chronic or progressive na-
ture, in which there is deterioration in cognitive function. This 
deterioration can be caused by a number of brain disorders or 
injuries that primarily or secondarily affect the brain, such as 
Alzheimer disease or stroke. Dementia affects higher cortical 
functions such as memory, thinking, comprehension and judg-
ment. This impairment is commonly accompanied by a decline 
in emotional control, social behaviour, or motivation [13]. Di-
agnosis is conventionally made when cognitive decline affects a 
person’s ability to carry out daily routine activities [14]. Many 
different forms or causes of dementia exist. Alzheimer disease is 
the most common, contributing to 60–70% of cases. It is char-
acterised by cortical amyloid plaques and neurofibrillary tangles, 
and symptoms include a gradual onset of impaired memory, 
apathy and depression [14]. Early-onset Alzheimer disease can 
present before the age of 65 and normally has a genetic cause 
[15]. Vascular dementia accounts for 20–30% of dementia [14]. 
It is diagnosed when the brain’s oxygen supply is compromised 
by repeated strokes or other blood vessel pathology, leading to 
accumulated damage to brain tissue and function [15]. Symp-
toms are similar to those of Alzheimer disease although memo-
ry is less affected and mood fluctuations are more [14]. Other 
common subtypes are frontotemporal dementia (5–10%) and 
Lewy body dementia (<5%). Post-mortem studies have suggest-
ed that boundaries between different forms are indistinct and 
subtypes often co–exist [14]. Dementia is largely under-diag-
nosed and often by the time of diagnosis patients are at a late 
stage in the disease process [16]. This is a particular issue in low 
and middle income countries (LMICs), as families may not un-
derstand their relative’s behaviour [14]. Early diagnosis is help-
ful so that everyone involved can be better equipped to deal with 
the disease and know what to expect [15].
Risk factors
The main risk factor for dementia is advancing age, and after 
the age of 65 the prevalence doubles every five years [17]. The 
environment is thought to influence the development of the dis-
ease, although little is understood about the underlying mecha-
nisms [15]. Other suspected risk factors include: (i) cardiovas-
cular problems; (ii) excessive alcohol consumption; (iii) social 
isolation; (iv) head injury; and (v) having one or two copies of 
the APOEε4 genetic variant. However, moderate alcohol con-
sumption and oestrogen have been reported to reduce the risk 
of developing dementia [18].
Course and outcome
Dementia is usually progressive and irreversible unless a cause 
is identified and treated effectively. Each person is affected in a 
different way, with varying speed of deterioration. Generally, the 
lifespan of the affected person is reduced [15]. Disease course 
is normally characterised into three stages: early, middle and 
late. The early stage is often overlooked as ‘old age’. However, 
as the disease progresses into the middle stage limitations be-
come clearer and more restricting. By the late stage, the person 
affected becomes nearly entirely dependent, with severe mem-
ory disturbances and physical symptoms [14].
Management
Currently, no treatments to cure or alter the progression of de-
mentia exist. Patients can be treated symptomatically with phar-
macological or psychosocial interventions. The latter are often 
highly effective and should be the first choice when managing 
behavioural problems [15]. Moreover, the provision of informa-
tion and support has been shown to reduce the psychological 
distress often experienced by carers [15].
Resources and prevention
Primary preventive intervention is a highly cost-effective, yet 
neglected area. Effective interventions could significantly reduce 
dementia prevalence and incidence, improve the quality of life 
of patients and carers, and reduce the resources needed to pro-
vide adequate institutional and home health care [19].
Box 2 A summary of background information on dementia
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Table 1 Search terms
1 Prevalence/ or incidence/ or morbidity/ or mortality/
2 (prevalen* or inciden*).mp.
3 (disease adj3 burden*).mp.
4 1 or 2 or 3
5 Dementia.tw.
6 Alzheimer*.tw.
7 5 or 6
8
Exp Africa/ or exp africa, northern/ or exp algeria/ or exp egypt/ 
or exp libya/ or exp morocco/ or exp tunisia/ or “africa south of 
the sahara”/ or africa, central/ or exp cameroon/ or exp central 
african republic/ or exp chad/ or exp congo/ or exp “democratic 
republic of the congo”/ or equatorial guinea/ or exp gabon/ or exp 
africa, eastern/ or exp burundi/ or exp djibouti/ or exp eritrea/ or 
exp ethiopia/ or exp kenya/ or exp rwanda/ or exp somalia/ or 
exp sudan/ or exp tanzania/ or exp uganda/ or exp africa, south-
ern/ or exp angola/ or exp botswana/ or exp lesotho/ or exp ma-
lawi/ or exp mozambique/ or exp namibia/ or exp south africa/ 
or exp swaziland/ or exp zambia/ or exp zimbabwe/ or exp africa, 
western/ or exp benin/ or exp burkina faso/ or exp cape verde/ or 
exp cote d'ivoire/ or exp gambia/ or exp ghana/ or exp guinea/ or 
exp guinea-bissau/ or exp liberia/ or exp mali/ or exp mauritania/ 
or exp niger/ or exp nigeria/ or exp senegal/ or exp sierra leone/ 
or exp togo/
9 4 and 7 and 8
10 Limit 9 to (humans and yr = ”1980-Current”)
Africa, any age-group or sex; (iii) reporting prevalence of 
dementia. We excluded all studies that were either hospital-
based, published before 1980, studies without a numerical 
estimate for prevalence, studies with subjects not human, 
or review articles (see Figure 1). We then evaluated the re-
tained studies for quality of their design and methods. We 
required a clear case definition of dementia, with a defined 
nominator, denominator and time frame of the study, ap-
propriate study design for a prevalence study, and adequate 
explanation of processes undertaken, including recruit-
ment of subjects (see Figure 2 and Table 2). Case defini-
tions were mostly similar, with considerable overlap be-
tween studies, and they should not have had a significant 
influence on the analyses (Table 3). Hospital–based stud-
ies were excluded; it cannot be presumed that everyone in 
LMIC has access to medical facilities and dementia may be 
secondary to another condition, for which the patient has 
been hospitalised.
Data extraction
Study characteristics and other relevant data were extracted 
from each retained article and entered into Microsoft Excel 
spreadsheet. Noted study characteristics include: country, 
region, period of study, setting, sample, age of participants, 
population characteristics, study size and type of assessor 
(see Online Supplementary Document). Wherever more 
than one article referred to the same study site / cohort, the 
first chronologically published paper was entered into the 
database and all additional data from other papers were 
added to the initial study (see Online Supplementary Doc-
ument for further details). All data on dementia prevalence 
and the prevalence of its two most important subtypes (Al-
zheimer disease and vascular dementia) were extracted: the 
Figure 1 A summary of search strategy used to identify the 
studies relevant to estimating the prevalence of dementia in 
Africa.
Table 2 Characteristics of studies included in the review
CharaCteristiC: No. of studies
Country: 
All 10
Nigeria 4
Egypt 2
Benin 2
South Africa 1
Central African Republic 1
Democratic Republic of the Congo 1
Duration of study:
<1 years 5
1–2 years 4
3–4 years 1
Sample size:
0–1000 4
1001–2000 3
2001–3000 2
>3000 1
Setting:
Urban 6
Rural 2
Urban and Rural 2
December 2012  •  Vol. 2 No. 2 •  020401 4 www.jogh.org  •   doi: 10.7189/jogh.02.020401
V
IE
W
PO
IN
TS
PA
PE
RS
An estimate of the prevalence of dementia in Africa
Figure 2 Geographic locations of retained studies with overall 
prevalence estimates; most studies were active in the period 
2002–2009.
total sample size for each study, number of cases with dis-
ease, and the prevalence in the overall sample. In addition, 
we extracted each prevalence which was reported within a 
specific age–group, whether it was disaggregated by gender 
or not (see Online Supplementary Document).
Data analysis
Our aim was to establish the pattern of relationship between 
person's age and likelihood to suffer from dementia (or its 
two subtypes) across the age range starting from 50 years of 
age until death, where the overwhelming majority of cases 
(>99%) are expected to occur in the population. This rela-
tionship was modelled based on the available information 
from all retained studies. All the extracted information from 
individual studies was plotted in a graph defined by age (x–
axis) and prevalence of dementia (or its 2 subtypes; y–axis). 
The coordinate on x–axis was defined as the mean age of the 
persons included in each (sub)sample, while the coordinate 
on y–axis was defined by the reported prevalence in that 
(sub)sample. The size of the “bubble” plotted in the graph 
was proportional to sample size relevant to each individual 
Table 3 Case definitions and screening measures of dementia in retained studies
author CouNtry Case defiNitioN sCreeNiNg measures CompliCatioNs
Ben-Arie (1983) [24] South Africa n/a MMSE, PSE, FCA
Life Satisfaction Index
Social Performance Schedule
El Tallawy (2010) [25] Egypt n/a SSQ, FCA Other neurological conditions
Farrag (1998) [26] Egypt
DSM–III–R
NINCDS–ADRDA
Hachinski Ischaemic Score
SSQ, MMSE, FCA, 
laboratory diagnosis
IADL
Geriatric Depression Scale
Revised Weschler Adult Intelligence Scale
Guerchet (2009) [27] Benin
DSM–IV
NINCDS–ADRDA
SSQ, CSI–D, FCA
Goldberg’s Anxiety and Depression Scale
Jacoby’s Stigma Scale
Psychosocial factors according to Persson and 
Skoog
Medical examination
Guerchet (2010) [28]
Central Republic of Africa
Democratic Republic of 
the Congo
DSM–IV
NINCDS–ADRDA
Hachinski Ischaemic Scale
SSQ, CSI–D, 5WT, 
FCA
Medical history
Psychosocial factors according to Persson and 
Skoog
Goldberg’s Anxiety and Depression Scale
Gureje (2006) [29] Nigeria DSM–IV 10WDRT
World Mental Health Survey version of WHO 
Composite International Diagnostic Interview
Katz Index of Independence of Daily Living
Nagi Physical Performance Scale and Health 
Assessment Questionnaire
WHO-QOL-BREF
Hendrie (1995) [30] Nigeria
DSM–III–R
ICD–10
SSQ, CSI–D, CERAD n/a
Ochayi (2006) [11] Nigeria
DSM–IV
ICD–10
CSI–D Medical examination
Paraiso (2011) [12] Benin
DSM–IV
NINCDS–ADRDA
NINDS–AIREN
SSQ, CSI–D, FCA
Medical examination
Goldberg’s Anxiety and Depression Scale
Psychosocial factors according to Persson and 
Skoog
Yusuf (2011) [31] Egypt
DSM–IV
ICD–10
SSQ, CSI–D, 
CERAD, SDT, BDS
n/a
DSM – Diagnostic and Statistical Manual of Mental Disorders, NINCDS–ADRDA – National Institute of Neurological and Communicative Disorders and 
Stroke – Alzheimer Disease and Related Disorders Association, ICD–10 – International Classification of Diseases – 10, NINDS–AIREN – National Insti-
tute of Neurological Disorders and Stroke – Association Internationale pour la Recherché et l'Enseignement en Neurosciences, MMSE – Mini Mental 
State Examination, PSE – portal–systemic shunt encephalopahty, FCA – Family Caregiver Alliance, SSQ – Speech, Spatial and Qualities of Hearing Scale, 
CSI-D – CommunityScreening Interview for Dementia, 5WT – Five Word Test, 10WDRT – 10–Word Delay Recall Test, CERAD – Consortium to Estab-
lish a Registry for Alzheimer Disease, SDT – sibship disequilibrium test, BDS – Blessed Dementia Scale, IADL – Instrumental Activities of Daily Living
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source of information. For all age groups that were not ful-
ly defined, such as eg, “60+ years”, mean age was deter-
mined as the age that comprised 50% of the population in 
this age group in the country where the study was under-
taken, according to the UN Population Division's estimates 
for the year of study. Graphs were then plotted with mean 
age on x-axis and dementia prevalence on y-axis, taking into 
account sample sizes which were represented by circle size 
(see eg, Figure 3). Graphs were drawn for both dementia 
and its two most common forms – Alzheimer disease and 
vascular dementia; for dementia, two additional analysis 
were possible – for men and women.
Given that the lowest mean age for any (sub)sample de-
fined in the retained studies was 54.5, we defined the age 
group of 0–54 years as the one where no data were avail-
able, and assumed that the prevalence of dementia in that 
age group was close to zero. Thereafter, the information on 
the prevalence was organised by 5–year age groups (from 
55–59 years; 65–74 years; 75–84 years; and 85 years and 
over). The weighted mean prevalence and standard devia-
tion were then calculated for each of those four age-groups 
for dementia (Table 4), Alzheimer disease (Table 5) and 
vascular dementia (Table 6). Weighted mean prevalence 
was calculated as an average of the prevalence multiplied 
by sample size, while 95% confidence intervals were cal-
culated from the standard errors of prevalence values.
To compute the overall burden of dementia, Alzheimer dis-
ease and vascular dementia in Africa, an epidemiological 
model was developed using meta–regression–like approach. 
A fundamental difference in this study was that the goal of 
this regression analysis was not to investigate the association 
between age and prevalence, but rather to use available data 
to predict the most likely prevalence at any given age after 
50 years. The model with best “fit” (largest proportion of 
variance explained) was used for each disease (Figures 3, 
4 and 5). The equation of the trendline was then used to 
compute the predicted prevalence at the ages of 52, 57, 62, 
67, 72, 77 and 87 years, which are mid–points of the UN 
Population Division's 5–year age group population esti-
mates for Africa in 2010. We multiplied the predicted prev-
alence at each age with total population in the correspond-
ing age groups to compute the total number of people living 
with dementia and its two main forms in Africa.
RESULTS
Systematic review
An initial screen of three databases returned 255 results 
from Medline, 273 results from EMBASE and 109 results 
from Global Health. After excluding duplicates, 331 titles 
were reviewed for relevance and only 47 studies were se-
lected for review of abstract. Wherever the abstracts lacked 
a numerical estimate for prevalence, full texts were sourced. 
Figure 3 Age–specific prevalence of dementia in Africa based on 
the information from 10 studies, with sample size underlying 
each data point presented by the size of each bubble.
Table 4 Age–specific weighted mean prevalence (%) of dementia in Africa
age group (years) 55–64 65–74 75–84 85+
No. of data points 2 12 8 8
Mean age (years) 58.25 70.12 80.00 88.92
Weighted mean prevalence and standard error (in %) 2.17 (0.84) 5.66 (1.69) 6.14 (2.72) 12.94 (3.71)
Table 5 Age–specific weighted mean prevalence (%) of Alzheimer disease in Africa
age group (years) 55–64 65–74 75–84 85+
No. of data points 1 6 7 4
Mean age (years) 62 70.15 78.45 87.42
Weighted mean prevalence and standard error (in %) 0.8 (–) 2.11 (1.05) 3.27 (3.23) 10.99 (7.81)
Table 6 Age–specific weighted mean prevalence (%) of vascular dementia in Africa
age group (years) 55–64 65–74 75–84 85+
No. of data points 1 5 7 3
Mean age (years) 62 70.28 78.42 87.23
Weighted mean prevalence and standard error (in %) 0.3 (–) 0.94 (0.47) 0.63 (0.86) 2.88 (2.14)
George-Carey	et	al.
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Eventually, only 10 studies were retained for the final re-
view and data extraction [8,10-12,24,27,29-32]. The lit-
erature search process is outlined in Figure 1.
Study characteristics
The majority of studies took place in Western Africa, with 
no studies conducted in Eastern Africa. The EDAC Survey 
found the prevalence of dementia in two Central African 
countries, the Central African Republic and the Democrat-
ic Republic of the Congo [8]. The clustering of studies in 
Nigeria could be attributed to the longitudinal study on the 
prevalence and incidence of dementia and Alzheimer dis-
ease in Yoruba people [30]. Half of the studies were con-
ducted within less than one year. The mean sample size 
was 7263, but this is mainly a result of significant skewing 
due to one large study with 62 583 participants; the mean 
sample size of the other 9 studies was 1004. Studies were 
largely conducted in urban areas, with two of them con-
ducted in both urban and rural settings. The majority of 
studies focused on prevalence in adults aged 65 years or 
more (Table 2).
Case definitions
Table 3 shows the case definitions and screening and com-
plication measures used in each study. DSM and NINCDS–
ADRDA were the most common criteria for Alzheimer dis-
ease diagnosis. ICD–10 and Hachinski Ishaemic Scale were 
used to diagnose vascular dementia. Modified versions of 
CSI-D and questionnaires were the most commonly used 
screening instruments. Diagnosis criteria for dementia are 
relatively adaptable to the community setting. However, 
most of the studies modified the screening instruments for 
the low literacy levels and local languages of the communi-
ties being examined, often involving the exclusion of sec-
tions of tests and adapting the diagnosis score. Many used 
an informant, often a family member, to gather a reliable 
history. Teams consisting of psychiatrists, clinical psycholo-
gists, neuropsychiatrists, neurologists, physicians or trained 
interviewers screened all of the populations.
Determination of participants’ age
As a rule, the age of each participant was verified in an of-
ficial document, which in many cases involved birth cer-
tificates. However, in six of the studies there were substan-
tial problems with age estimates in a considerable 
proportion of the participants, when official birth records 
were unavailable. In such cases, local historical landmark 
events were used to estimate the age of participants. This 
has been shown to be an accurate method of age estima-
tion [12].
Prevalence estimates
All 10 retained studies reported numerical estimates for 
dementia prevalence, with age breakdown of prevalence 
available from all studies but one [24]. No prevalence was 
recorded until the age of at least 50. Age groups 65–74 and 
75–84 typically provided the most data points. Figures 3, 
4 and 5 and Tables 4, 5 and 6 show that the prevalence of 
dementia grows from about 2% at the age of 60 to nearly 
13% at the age of 90, with a trend to reach more than 25% 
at the age of 100. In comparison, Alzheimer disease has a 
prevalence of about 1% at 60 years, 2% at 70 years and 
slightly above 3% at 80 years, but then accelerates rapidly 
to more than 11% at the age of 90. In comparison, vascu-
lar dementia seems to reach about 1% of prevalence after 
the age of 60, but then the prevalence remains relatively 
stable and only begins to increase after the age of 85, to 
about 3%.
Although meta-analysis of the 10 retained studies in Africa 
would suggest that about 73% of the cases of dementia were 
Alzheimer disease and about 15% vascular dementia, those 
studies had a predominance of elderly people, and were 
therefore not representative of the current African popula
Figure 4 Age–specific prevalence of Alzheimer disease in Africa, 
with sample size underlying each data point presented by the 
size of each bubble.
Figure 5 Age–specific prevalence of vascular dementia in Africa, 
with sample size underlying each data point presented by the 
size of each bubble.
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tion. The extrapolation of our findings to the current Afri-
can population suggests that Alzheimer disease is currently 
responsible for 57.2% of all dementia cases in Africa, and 
vascular dementia for 26.9%, but with the former having a 
an increasing trend in relative importance (Figure 6).
We were also interested in investigating any differences in 
sex-specific prevalence of dementia. The only disease with 
sufficient evidence on gender breakdown was dementia, 
where 7 studies could be used. Table 7 shows that females 
seem to have higher overall prevalence, particularly in very 
old age groups, although these data are based on relatively 
little information and surrounded with large uncertainty.
Finally, the overall prevalence of dementia in adults older 
than 50 years in Africa was estimated to be about 2.4%, 
which translates to 2.76 million people living with a dis-
ease in 2010, and about 2.10 millions of them live in sub-
Saharan Africa. Further details are provided in Table 8.
Risk factors for dementia
Eight papers reported on risk factors for dementia, in addi-
tion to prevalence estimates. The main findings are report-
ed below and tabulated in Online Supplementary Docu-
ment. All studies established increasing age as the strongest 
risk factor for the prevalence of dementia, with four studies 
also showing higher prevalence among females. Education 
is thought to be protective against dementia [31], so higher 
prevalence in women in Africa may reflect lower education-
al attainment and poorer socioeconomic status, another 
recognised risk factor for dementia [32]. The only study that 
carried out APOE genotyping reported higher prevalence of 
dementia in people with APOEε4 [27]. Poor nutritional sta-
tus may also exacerbate the risk of developing dementia 
[18], and one study found a BMI<18.5 to be associated with 
dementia prevalence [11]. Another study found a lifetime 
of excessive alcohol consumption to double the risk demen-
tia compared to those who were abstinent for life [29]. Hy-
pertension and diabetes are emerging as significant endem-
ic threats in Africa [8], which is notable as two of the 
studies reported cardiovascular problems as risk factors for 
vascular dementia: one study reported higher prevalence in 
urban areas [12], while another one reported higher preva-
lence in rural areas [29]. Other studies did not find study 
setting to represent a significant risk factor.
DISCUSSION
This paper identified and analysed 10 studies reporting 
prevalence of dementia in African countries in order to pro-
vide an estimate for the overall prevalence of dementia in 
persons aged 50 years or more in Africa. It was conducted 
with an aim to provide recommendations for future poli-
cies and research.
Figure 6 Proportional contribution of different types of dementia 
to the overall burden in Africa.
Table 7 A comparison of age–specific weighted mean prevalence of dementia in African men and women
age group (years) 60–69 70–79 80+
Men:
No. of data points 2 7 2
Mean age (years) 64.50 72.83 84.87
Weighted mean prevalence and standard error (in %) 1.93 (0.88) 2.60 (2.17) 16.83 (3.58)
Women:
No. of data points 2 7 2
Mean age (years) 64.5 74.5 84.5
Weighted mean prevalence and standard error (in %) 1.35 (0.10) 5.22 (2.62) 19.68 (10.00)
Table 8 The estimates of the total number of cases of dementia, Alzheimer disease, vascular dementia and other forms of dementia in 
Africa in the year 2010 (figures in brackets: Sub–Saharan Africa only)
age group (years) all demeNtia alzheimer disease VasCular demeNtia other forms
0–54 308 513 (235 380) 96 608 (73 707) 185 615 (141 615) 26 290 (20 058)
55–59 352 334 (270 845) 130 713 (100 481) 128 145 (98 507) 93 476 (71 857)
60–64 388 370 (300 607) 170 352 (131 856) 101 769 (78 771) 116 250 (89 980)
65–69 401  815 (317 297) 208 666 (164 775) 89 998 (71 068) 103 151 (81 454)
70–74 399 054 (303 042) 245 459 (186 402) 84 044 (63 823) 69 550 (52 817)
75–79 342 986 (254 173) 249 838 (185 145) 69 972 (51 854) 23 176 (17 174)
80+ 571 692 (413 919) 479 437 (347 124) 86 583 (62 688) 5673 (4107)
Total 2 764 764 (2 095 263) 1 581 073 (1 189 491) 746 126 (568 326) 437 565 (337 447)
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Findings
The overall prevalence of dementia in Africa in person aged 
50 years or older, as modelled from 10 studies of sufficient 
quality and using UN’s population estimates, was about 
2.4%, which translates to 2.76 million people living with 
a disease in 2010. About 2.10 millions of them live in Sub–
Saharan Africa. The highest reported prevalence was 10.1% 
across eight contiguous states in Nigeria and the lowest was 
1.12% in Ibadan, Nigeria. The former value was from a 
study carried out in 2006, while the latter was in 1995, 
which may explain the large discrepancy between the two 
results from the same country. Age–specific analysis showed 
a general trend of an exponential increase in prevalence 
with age. The rough doubling of dementia prevalence ev-
ery five years after the age of 65 is well documented in de-
veloped countries. The protective effect of oestrogen against 
dementia may account for lower prevalence of females in 
the 55–64 age group [18]. Alzheimer disease was found to 
be the most prevalent cause of dementia, followed by vas-
cular dementia, and these findings match those of devel-
oped countries.
Previous estimates of dementia prevalence in Africa have 
been provided by the Alzheimer Disease International us-
ing a Delphi consensus study (for the years 2001 and 
2020), and by the WHO (for the year 2010) [13,33]. The 
former predicted about 0.5 million affected persons in 
2001 and 0.9 in 2020, although this estimate was restrict-
ed to Sub–Saharan Africa. It is apparent that the estimate 
based on expert opinion has already grossly underestimat-
ed the burden of this problem [33], which in our study al-
ready reached 2.1 million of sufferers in Sub–Saharan Af-
rica in 2010. The WHO's estimate for 2010, of 1.9 million 
affected people in the population aged over-60, is much 
closer to our estimate which quotes the corresponding fig-
ure of about 2.1 million in persons over 60 years old. Our 
review estimates that at least 2.7 million people aged 50 
years or more are living with dementia in Africa in 2010.
Limitations
While this review aimed to provide the best possible esti-
mate for the prevalence of dementia in Africa, there are fea-
tures that may have limited the results. The overall data on 
dementia in Africa is insufficient, with only ten studies suit-
able for inclusion, and with the gender-aggregated and de-
mentia subtypes prevalence available from only seven and 
six of the studies, respectively. All of the studies included 
data from >139 subjects, and one sample size was particu-
larly large [25]. The similarity of prevalence values suggests 
that the range of sample sizes did not substantially skew 
the results. Methodologies did not vary too widely among 
studies, allowing for direct comparisons. The search was 
limited to 1980 – present time, although most of the stud-
ies were active between 2002 and 2009. Considering the 
life expectancy at birth for Africans in 1980 was 48.5 years, 
it is unlikely that many, if any, prevalence studies for de-
mentia were conducted before 1980 [34].
Case definitions of dementia, Alzheimer disease and vas-
cular dementia were similar enough, with considerable 
overlap between them, for the results to be comparable. 
Misclassification bias may have occurred due to commu-
nication difficulties during assessment, especially as there 
is no definitive clinical diagnosis for dementia. It has been 
suggested that DSM–IV dementia criteria might underesti-
mate dementia prevalence, especially in areas with low 
awareness of the emerging problem [8,35,36]. Another 
cause of underestimation is informant participation in the 
use of CSI–D, because of the cultural specific differences 
that prevent informants from disclosing information that 
could compromise their parents’ integrity [12], so that in-
formants may give answers they think are acceptable rath-
er than accurate [10]. Other notable aspects of the CSI–D 
instrument are that it should be independent of education-
al and cultural background of the subject, making it suit-
able where literacy level is low, and that it may have diffi-
culty distinguishing depression from dementia [11].
All included studies were community-based, in order to 
avoid many biases present in facility-based studies or in 
other studies relevant only to specific population sub-
groups. Still, the quality of data is heavily reliant on the sen-
sitivity and specificity of the screening methods and diag-
nostic criteria. Only three of the retained studies reported 
sensitivity and specificity of methods [11,12,29]. Standar-
disation of these tools is important to limit observational 
bias. Results may have depended on who the assessor was, 
with some assessors likely having more experience in de-
mentia diagnosis than others, such as neurologists. Anoth-
er concern is the focus of studies on certain regions in Af-
rica. No studies were conducted in Eastern Africa, while six 
took place in Western Africa. Moreover, the general tenden-
cy of higher rates of illiteracy in rural areas, where many 
students leave school to work in the fields, may also poten-
tially cause comparability issues.
Awareness and diagnosis of dementia in 
developing countries
An ongoing debate on the lower prevalence of dementia in 
developing countries centres around the fact that the elder-
ly in these regions are not expected to involve themselves 
in the instrumental activities of daily living (IADL) [31]. The 
living environment is often without sophisticated utilities, 
and therefore poses little cognitive challenge. Additionally, 
the social environment is one that protects the elderly rath-
er than imposing tasks on them. This social environment 
which is relatively undemanding may mean that only those 
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with severe dementia are likely to match social impairment 
criteria and receive diagnosis, thus under-estimating the 
true size of the problem [29]. Research and media attention 
in Africa is also mainly given to the diseases with higher case 
fatality, such as HIV and malaria. In comparison, dementia 
has a low mortality but high morbidity and disability. The 
general lack of awareness of the disease has important con-
sequences: (i) help from medical services is not sought; (ii) 
no structured training exists on the recognition and man-
agement of dementia at any level of the health service; (iii) 
there is no constituency to place pressure on the govern-
ment or policy makers to provide more responsive demen-
tia care services; and (iv) families are the primary caregivers 
with little support from other individuals or agencies [15]. 
These features create a multi–faceted burden to the indi-
vidual, their family and society, which has personal, emo-
tional, financial and social aspects [17].
The affected person may experience ill health, disability, 
impaired quality of life and reduced life expectancy [14]. 
One study showed elevated odds for persons with demen-
tia to be disabled in all areas of activities of daily living 
(ADL) and also having lower quality of life [29]. These find-
ings correlate with the GBD reports, which indicate that 
dementia is one of the main causes of disability in later life 
[2]. Dementia can adversely affect communication, mem-
ory and mobility, creating dependence. It can affect sleep 
and mood, which can become a source of distress for care-
givers, while creating feelings of loneliness and social iso-
lation for the sufferers [15,37]. Due to the dependent na-
ture of dementia, family and friends become a vital support 
network, but the reliability and universality of family care 
systems in LMIC are often overestimated [15,37]. Although 
there are many potential caregivers, this may not always 
translate into adequate care [31]. With the growing middle 
class, this situation is likely to change as family structures 
evolve toward western models and family support becomes 
less available [12]. Carers within family will find them-
selves in a difficult position, where they can either stop 
working in order to care for the affected person, thus los-
ing the opportunity to earn income, or continuing with 
their work in parallel but reducing the outcomes for the 
affected. Caregiving is associated with high levels of psy-
chological strain, and family caregivers have been shown 
to have increased levels of affective disorders such as de-
pression and anxiety [13]. In addition, some studies re-
ported a common misconception in many African settings 
that there is no treatment for dementia, and that it is a nor-
mal part of ageing [25]. This poses a problem, as dementia 
recognition would improve disease outcomes [15]. Diag-
nosis is crucial in that it provides access to treatment, care 
and support across the disease course. Earlier diagnosis is 
important for the affected person, as it allows people to 
plan ahead while they still have the capacity to do so; it also 
enables their caregivers to become better equipped and 
prepared [15]. Another consequence of the growing middle 
class is that a larger proportion of the population will be 
educated and have a higher awareness of the disease and 
possible treatments [7]. They are therefore more likely to 
seek better health care for themselves and their families. 
Combined with the substantial increases in dementia prev-
alence, these factors will place a considerable strain on al-
ready resource-scarce health services. Considering both 
this strain and the disintegration of multigenerational fam-
ily structures, a purely health services response would be 
insufficient, and societal action is also needed.
Research evidence should inform the actions that are most 
needed, and each country should develop a priority re-
search agenda. The course of dementia epidemics needs 
to be monitored nationally, focusing on changes in preva-
lence and incidence that might indicate success or failure 
of efforts to control it. Significantly more research is re-
quired to understand the causes of dementia, and how do 
lifestyle factors influence the risk [13]. Lack of consisten-
cy in the methodologies and case definitions of dementia 
between studies may hinder the comparability of the data. 
In this study, inconsistencies in reporting on the reviewed 
examinees were an important issue when standardising 
data. Standards to ensure synchronisation of methods 
would be helpful, such as types of assessor and screening 
measures. Suggestions of criteria for future studies are 
shown in Table 9. Diagnosis of dementia according to 
DSM criteria requires: (i) impairment in short- and long-
term memory; (ii) impairment in abstract thinking or 
judgement, or impairment of higher cortical functions or 
personality changes; and (iii) evidence that the cognitive 
disturbances resulting from (i) and (ii) significantly inter-
fere with work, usual social activities or relationships with 
others [38]. DSM criteria were chosen over ICD criteria be-
cause (i) they are defined more precisely; and (ii) ICD cri-
teria are more dependent on informants, making them 
harder to apply to a community setting [39].
Although two-phase diagnosis studies are thought to in-
crease the rates of attrition before clinical assessment, some 
authors found them to be feasible in African countries due 
to high participation rates [8]. Trained investigators should 
be used, so that any additional burden on practicing phy-
sicians is avoided. All adults in the population aged 50 or 
older should be screened, to prevent missing a diagnosis 
of early–onset Alzheimer disease.
There are considerable further obstacles that should be ad-
dressed by policies to control dementia in Africa: (i) gener-
ally low priority of mental and neurological disorders; (ii) 
poor awareness and understanding of those diseases; and 
(iii) lack of infrastructure and resources [13]. Evidence 
from this review has shown that dementia prevalence in 
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Africa is increasing towards the levels that are present in 
developed countries, and this trend will continue to in-
crease at a faster rate than anywhere else in the world. Re-
sources need to be set aside to tackle this growing problem 
at national, local, family and personal levels. Attention 
must be given to reducing the burden of disease through 
timely and appropriate diagnosis and treatment, symptom 
management and reduction in exposure to risk factors. 
Public campaigns will need to be launched to fight com-
mon misconceptions regarding dementia, such as that: (i) 
it is not very common; (ii) it is a normal part of ageing; (iii) 
there is nothing that can be done to help; (iv) it is better 
not to know about it; and that (v) it is the responsibility of 
the family to provide care. The varying presentation and 
impact of dementia make it challenging to alter the social 
and cultural determinants of care–seeking behaviour. Many 
of the risk factors identified in this review, such as age and 
sex, require a grass–roots approach in order to raise aware-
ness of and educate the general public about dementia. It 
is important that people’s cultures and beliefs are consid-
ered when developing awareness–raising campaigns. Oth-
er risk factors are linked to the structural determinants of 
disease and require multi–sectoral action. It is important 
that health care workers are well trained in case manage-
ment of dementia, with the ability to efficiently assess, di-
agnose, treat or refer and educate patients and their care-
givers. This approach should limit distress in the affected 
person, reduce strain and build the confidence of carers, 
and reduce unnecessary consultations.
Strategies to raise awareness of dementia and improve the 
chance of early diagnosis include: (i) practice–based edu-
cational programmes in primary care; (ii) the introduction 
of accessible diagnostic and early stage dementia care ser-
vices (eg, memory clinics); and (iii) promoting effective 
interaction between different components of the health 
system [16]. With the growing middle class in Africa, es-
tablished cultural norms of care and social protection 
through extended family networks are no longer sustain-
able. A key policy priority therefore is to plan for the long-
term care of people with dementia. In addition, more re-
search needs to be commissioned and funded in order to 
improve understanding of the different social and environ-
mental risk factors.
Conclusion
The number of elderly people in Africa is increasing rap-
idly, with an accelerating number of the persons affected 
by dementia. Although the epidemiological literature on 
dementia in Africa is very limited, our estimates of the 
number of cases living with dementia in Africa suggest that 
this condition should already be considered a public health 
priority. The analysis of the study design of the available 
research indicated that the prevalence is likely to be under-
estimated, and that the true figures are likely to be consid-
erably higher. The evidence base of epidemiological data 
of dementia must be improved to fully understand the bur-
den and its impacts on individuals, families and societies. 
More research is needed in the entire Africa, but particu-
larly in the southern and eastern regions. Consistency in 
case definition and methodologies are vital in creating a re-
liable estimate. There is also a need for age– and sex–spe-
cific information in order to refine the existing burden es-
timates and provide specific targets for health programmes. 
Other research priorities include multiple collaborative 
community–based studies in the adult population and in-
vestigations of lifestyle factors that influence development 
of the disease. Policy recommendations include raising 
awareness of the disease through educational programmes 
in primary care, the introduction of diagnostic and early 
stage dementia care services in the community, and col-
laboration between different components of the health sys-
tem. Planning for the long–term care of sufferers and their 
families is encouraged in light of the growing middle class 
in Africa.
Table 9 Recommended criteria for future studies of dementia in the community
Criteria miNimum required staNdard
Case definition DSM criteria. Screening measures: SSQ, CSI–D & FCA. Complication screening measures: Goldberg’s Anxiety and Depression Scale, 
psychosocial factors according to Persson and Skoog, WHO–QOL–BREF.
Methodology Two–phase dementia diagnosis study. Door-to-door survey of all households. Interview prior to start of study should obtain demo-
graphic and risk factors.
Assessor Specially trained investigator; training includes symptom recognition, physical examination and patient communication skills.
Population All adults included, representative of community population. Replacement subjects matched to drop–outs. Prevalence and incidence 
data grouped by age (18–49 y, by 10 y thereafter), sex (M/F) and subtype (Alzheimer disease, vascular dementia, Lewy body de-
mentia, frontotemporal dementia and others).
Sample size >500 subjects
Duration >1 year
FCA – Family Caregiver Alliance, SSQ – Speech, Spatial and Qualities of Hearing Scale, CSI-D – Community Screening Interview for Dementia, 
WHO-QOL-BREF – WHO Quality of Life-BREF
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